Smyth R J, Uhlman E J, Ruggieri M R
Department of Pharmacology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.
J Urol. 1994 Apr;151(4):1102-6. doi: 10.1016/s0022-5347(17)35192-3.
The present study used radioligand binding and in vitro contractility experiments to identify and characterize a peripheral-type benzodiazepine receptor PBR in rabbit urinary bladder. [3H]PK11195 bound to bladder membranes with high-affinity and density (Kd = 5.2 nM., Bmax = 268 fmol./mg. protein), indicating the presence of a PBR. [3H]flunitrazepam bound with high-affinity and density (Kd = 1.2 nM., Bmax = 48 fmol./mg. protein). The rank order potency of various benzodiazepines and isoquinoline carboxamides in displacing the binding of [3H]PK11195 was Ro5-4864 > diazepam = flunitrazepam >> Ro15-1788 = clonazepam. Ro5-4864 and PK11195 inhibited nerve-evoked contractions in a concentration-dependent manner (IC50 = 42 microM. and 56 microM., respectively). Carbachol- and KCl-induced contractions were also inhibited by Ro5-4864 and PK11195. KCl-induced contractions were inhibited to a greater extent than carbachol-induced or field-stimulated contractions with all the drugs tested. Both Ro5-4864 and PK11195 significantly increased the ED50 for calcium-induced contractions following a cholinergic stimulus compared with control. These data demonstrate the presence of a PBR in urinary bladder capable of altering contractility in vitro through modulation of calcium activity.
本研究采用放射性配体结合和体外收缩性实验,以鉴定和表征兔膀胱中的外周型苯二氮䓬受体(PBR)。[3H]PK11195以高亲和力和密度与膀胱膜结合(解离常数Kd = 5.2 nM,最大结合容量Bmax = 268 fmol/mg蛋白质),表明存在PBR。[3H]氟硝西泮也以高亲和力和密度结合(Kd = 1.2 nM,Bmax = 48 fmol/mg蛋白质)。各种苯二氮䓬类药物和异喹啉甲酰胺在取代[3H]PK11195结合方面的效价顺序为:Ro5-4864 > 地西泮 = 氟硝西泮 >> Ro15-1788 = 氯硝西泮。Ro5-4864和PK11195以浓度依赖性方式抑制神经诱发的收缩(半数抑制浓度IC50分别为42 μM和56 μM)。Ro5-4864和PK11195也抑制了卡巴胆碱和氯化钾诱导的收缩。在所测试的所有药物中,氯化钾诱导的收缩比卡巴胆碱诱导的或场刺激诱导的收缩受到的抑制程度更大。与对照组相比,Ro5-4864和PK11195均显著增加了胆碱能刺激后钙诱导收缩的半数有效剂量(ED50)。这些数据表明膀胱中存在PBR,其能够通过调节钙活性在体外改变收缩性。